To: | Celgene Corporation (cmiller@cozen.com) |
Subject: | U.S. TRADEMARK APPLICATION NO. 88312294 - MYHOPE 360 - CELG- |
Sent: | 5/1/2019 10:26:05 AM |
Sent As: | ECOM108@USPTO.GOV |
Attachments: |
UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
OFFICE ACTION (OFFICIAL LETTER) ABOUT APPLICANT’S TRADEMARK APPLICATION
U.S. APPLICATION SERIAL NO. 88312294
MARK: MYHOPE 360
|
|
CORRESPONDENT ADDRESS: |
GENERAL TRADEMARK INFORMATION: http://www.gov.uspto.report/trademarks/index.jsp
|
APPLICANT: Celgene Corporation
|
|
CORRESPONDENT’S REFERENCE/DOCKET NO: CORRESPONDENT E-MAIL ADDRESS: |
|
EXAMINER’S AMENDMENT
DATABASE SEARCH: The trademark examining attorney has searched the USPTO’s database of registered and pending marks and has found no conflicting marks that would bar registration under Trademark Act Section 2(d). TMEP §704.02; see 15 U.S.C. §1052(d).
APPLICATION HAS BEEN AMENDED: In accordance with the authorization granted by Camille M. Miller on 04/30/2019, the trademark examining attorney has amended the application as indicated below. Please advise the undersigned immediately of any objections. Otherwise, no response is necessary. TMEP §707. Any amendments to the identification of goods and services may clarify or limit the goods and services, but may not add to or broaden the scope of the goods and services. 37 C.F.R. §2.71(a); see TMEP §§1402.06 et seq.
AMENDED IDENTIFICATION OF GOODS AND SERVICES
The identification of goods is amended to read as follows:
International Class 009: Downloadable computer software enabling patients to manage and access data relating to the treatment of cancer and immunological disorders; downloadable computer application software for use on mobile phones and mobile electronic devices for use in connection with providing medical information in the field of cancer and immunological disorders; downloadable electronic publications, namely, newsletters and articles featuring medical information in the field of cancer and immunological disorders; downloadable videos featuring medical information in the field of cancer and immunological disorders; downloadable computer software for application and database integration
International Class 42: Software as a Service (Saas) services featuring software that allows patients to manage and access data relating to the treatment of cancer and immunological disorders; application service provider (ASP) featuring software for medical affair management and information exchange; providing a website featuring non-downloadable software for medical affair management and information exchange; providing an on-line computer database featuring medical and scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, pharmacology and biotechnology; scientific research consultation pertaining to clinical trials; providing medical and scientific research information in the field of clinical trials
See TMEP §§1402.01, 1402.01(e).
/Salima Parmar Oestreicher/
Examining Attorney
Law Office 108
(571) 272-6786
salima.oestreicher@uspto.gov
PERIODICALLY CHECK THE STATUS OF THE APPLICATION: To ensure that applicant does not miss crucial deadlines or official notices, check the status of the application every three to four months using the Trademark Status and Document Retrieval (TSDR) system at http://tsdr.gov.uspto.report/. Please keep a copy of the TSDR status screen. If the status shows no change for more than six months, contact the Trademark Assistance Center by e-mail at TrademarkAssistanceCenter@uspto.gov or call 1-800-786-9199. For more information on checking status, see http://www.gov.uspto.report/trademarks/process/status/.
TO UPDATE CORRESPONDENCE/E-MAIL ADDRESS: Use the Trademark Electronic Application System (TEAS) form at http://www.gov.uspto.report/trademarks/teas/correspondence.jsp.